Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Phase of Trial: Phase III
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Registrational; Therapeutic Use
- Acronyms Protocol-V
- 10 Jun 2017 Biomarkers information updated
- 01 Jun 2016 Planned End Date changed from 1 Mar 2017 to 1 Aug 2018.
- 01 Jun 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2018.